08.00 |
![]() |
Registration and Coffee |
Introduction to IPAC-RS |
||
09.00 - 09.10 |
![]() |
Membership, structure, strategic priorities, overview of workstreams, accomplishments and impact |
Delivery Systems Workstream – activity update |
||
09.10 - 09.35 |
![]() |
Medical Device Regulations |
09.35 - 10.00 |
Human Factors Roisin Wallace, Mylan |
|
10.00 - 10.25 |
![]() |
Instructions for Use |
10.50 - 11.25 |
![]() |
Refreshment Break |
General Workstream -activity update |
||
10.50 -11.25 |
![]() |
A review of FDA draft guidance on Metered Dose Inhaler and Dry Powder Inhaler Drug Products – Quality Considerations |
CMC and Product Development Test Workstream – activity update |
||
11.25 - 12.00 |
![]() |
Cascade Impaction testing and data analysis, regulatory and pharmaceutical developments |